Bio-Rad Laboratories, Inc. (BIO.B) bonds
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$803.00M
Long-term debt
Net debt
$286.00M
After $517.00M of cash
Implied interest rate
4.08%
FY2025 interest ÷ average debt
Interest coverage
1.0×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Bio-Rad Laboratories's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| 3.3%, Senior Notes due 2027 | 3.30% | 2027 | – | – |
| 3.3%, Senior Notes due 2027 | – | 2027 | $400.00M | $395.70M |
| 3.7%, Senior Notes due 2032 | – | 2032 | $800.00M | $790.50M |
| 3.7%, Senior Notes due 2032 | 3.70% | 2032 | – | – |
| Other Long-Term Debt | – | – | – | $9.80M |
| Senior Notes | 101.00% | – | – | – |
| Senior Notes | – | – | – | $1.19B |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.